Milestone Scientific (NYSE:MLSS) Now Covered by StockNews.com

StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS) in a report issued on Sunday. The brokerage issued a hold rating on the stock.

Separately, Benchmark initiated coverage on shares of Milestone Scientific in a research note on Thursday, October 10th. They issued a “speculative buy” rating and a $1.25 target price for the company.

Milestone Scientific Stock Performance

MLSS opened at $0.68 on Friday. The company’s 50-day simple moving average is $0.88 and its two-hundred day simple moving average is $0.84. Milestone Scientific has a 52-week low of $0.52 and a 52-week high of $1.10. The stock has a market capitalization of $52.14 million, a P/E ratio of -9.64 and a beta of 1.08.

Milestone Scientific (NYSE:MLSS) last released its earnings results on Thursday, August 15th. The company reported ($0.02) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.01). The company had revenue of $1.85 million during the quarter. Milestone Scientific had a negative return on equity of 60.78% and a negative net margin of 54.87%.

Insider Activity at Milestone Scientific

In other Milestone Scientific news, Director Leonard Osser sold 107,984 shares of the stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total transaction of $100,425.12. Following the sale, the director now owns 4,606,882 shares in the company, valued at approximately $4,284,400.26. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders have sold a total of 251,106 shares of company stock worth $236,451 in the last three months. Insiders own 24.75% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.